Aarti Pharmalabs (NSE:AARTIPHARM) Enterprise Value : ₹79,877 Mil (As of May. 21, 2025)

Aarti Pharmalabs Enterprise Value Chart

Aarti Pharmalabs Quarterly Data
	Mar21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Enterprise Value	Get a 7-Day Free Trial									41,329.99	55,381.55	60,524.97	62,192.09	71,425.97

Competitive Comparison of Aarti Pharmalabs's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Pharmalabs's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aarti Pharmalabs's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Pharmalabs's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Aarti Pharmalabs's Enterprise Value falls into.

Aarti Pharmalabs Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Aarti Pharmalabs's Enterprise Value for the fiscal year that ended in Mar. 2025 is calculated as

Aarti Pharmalabs's Enterprise Value for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aarti Pharmalabs  (NSE:AARTIPHARM) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Aarti Pharmalabs's EV-to-EBIT for today is

Aarti Pharmalabs's current Enterprise Value is ₹79,877 Mil.
Aarti Pharmalabs's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,876 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Aarti Pharmalabs's EV-to-EBITDA for today is:

Aarti Pharmalabs's current Enterprise Value is ₹79,877 Mil.
Aarti Pharmalabs's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,745 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Aarti Pharmalabs's EV-to-Revenue for today is:

Aarti Pharmalabs's current Enterprise Value is ₹79,877 Mil.
Aarti Pharmalabs's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹21,151 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Aarti Pharmalabs's EV-to-FCF for today is:

Aarti Pharmalabs's current Enterprise Value is ₹79,877 Mil.
Aarti Pharmalabs's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aarti Pharmalabs Enterprise Value Related Terms

Thank you for viewing the detailed overview of Aarti Pharmalabs's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Aarti Pharmalabs Business Description